AvePoint Reports Strong Q1 2026 Results with 26% Revenue Growth and Significant Share Repurchases
AVPT sits 15% above its 52-week low of $8.835 on elevated volume (2.9× avg).
Summary
AvePoint reported strong Q1 2026 financial results with significant revenue and net income growth, alongside substantial share repurchases, indicating robust operational performance and shareholder value creation.
Key Events · Earnings and Guidance · AVPT
-
Strong Revenue Growth
Total revenue increased 26.0% year-over-year to $117.2 million, with SaaS revenue growing 35.5% to $93.4 million, representing 80% of total revenue.
-
Significant Profitability Improvement
Net income surged to $15.3 million in Q1 2026 from $3.6 million in Q1 2025, and income from operations increased from $3.3 million to $12.7 million.
-
Robust ARR Expansion
Annual Recurring Revenue (ARR) grew 26% year-over-year to $435.2 million as of March 31, 2026.
-
Substantial Share Repurchase
The company repurchased 5,412,958 shares for approximately $59.8 million during the quarter, with $39.8 million remaining under the current authorization.
Analysis · AVPT · Technology
AvePoint, Inc. delivered robust first-quarter 2026 financial results, showcasing accelerated growth in SaaS revenue and a substantial increase in profitability. The company's total revenue grew 26.0% year-over-year, driven by a 35.5% surge in SaaS revenue, which now constitutes 80% of total revenue. This strong top-line performance translated into a significant improvement in net income, which more than quadrupled compared to the prior year. Furthermore, AvePoint generated substantial operating cash flow and continued its share repurchase program, buying back nearly $60 million in common stock during the quarter. These results highlight strong operational execution and a commitment to returning capital to shareholders, reinforcing a positive investment thesis.
At the time of this filing, AVPT was trading at $10.20 on NASDAQ in the Technology sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $8.84 to $20.25. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.